Abbott India has informed that in terms of Regulation 29 (1) (a) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, a Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, August 8, 2017, to consider and approve the text of Unaudited Financial Results of the Company for the first quarter ended on June 30, 2017. Further, in terms of Abbott India Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the Trading Window of the Company shall remain closed from Tuesday, August 1, 2017 to Thursday, August 10, 2017.
The above information is a part of company’s filings submitted to BSE.
